Amneal Pharmaceuticals manufactures, markets and/or distributes more than 88 drugs in the United States.
Amneal is much more than just a company. It is a remarkable collection of dynamic and innovative people dedicated to the constant pursuit of excellence.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Oct 1, 2017 | Post-IPO Equity | $854M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
TPG | — | Post-IPO Equity |